{"entity": "publication", "iuid": "a31d4b6f1d68467b8c5afe4b87361694", "timestamp": "2026-08-20T20:26:39.895Z", "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/publication/a31d4b6f1d68467b8c5afe4b87361694.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/publication/a31d4b6f1d68467b8c5afe4b87361694"}}, "title": "PARP inhibitor receives FDA breakthrough therapy designation in castration resistant prostate cancer: beyond germline BRCA mutations.", "authors": [{"family": "Helleday", "given": "T", "initials": "T"}], "type": "editorial", "published": "2016-05-00", "journal": {"title": "Ann. Oncol.", "issn": "1569-8041", "volume": "27", "issue": "5", "pages": "755-757", "issn-l": "0923-7534"}, "abstract": null, "doi": "10.1093/annonc/mdw048", "pmid": "26865580", "labels": [], "xrefs": [{"db": "pii", "key": "S0923-7534(19)37429-0"}], "notes": [], "created": "2026-08-20T09:38:48.957Z", "modified": "2026-08-20T09:38:48.997Z"}